HMLT, a histidine-modified melittin derivative, treats severe acute pancreatitis by restoring oxidative balance and macrophage metabolism with significantly less toxicity than natural bee venom peptide.
Reduced toxicity, maintained efficacyHistidine-modified melittin retains anti-inflammatory power with lower cytotoxicity
What the researchers found
HMLT, a histidine-substituted melittin derivative, ameliorates SAP by restoring oxidative homeostasis and macrophage metabolism with significantly reduced cytotoxicity versus native melittin.
Why it matters
Severe acute pancreatitis kills 20-30% of patients and has no specific treatment. A detoxified version of a potent natural anti-inflammatory peptide could become the first targeted therapy.
How the study worked
Peptide design with histidine substitutions; cytotoxicity comparison; SAP models evaluating oxidative stress, macrophage metabolism, and anti-inflammatory efficacy.
What this study cannot tell us
Preclinical study; SAP models may not fully replicate human disease complexity; optimal dosing and route for human use not established.
How to read the evidence
Preclinical study with rational drug design — strong proof of concept but no human data.
When this study was published
Published in 2026, advancing venom-derived peptide therapeutics for critical illness.
The bigger picture
This demonstrates how rational peptide engineering can tame toxic natural products into potential medicines — taking evolution's powerful molecular weapons and removing their destructive side effects.
Questions still open
- Could HMLT be administered intravenously during acute pancreatitis attacks in humans?
- Does the histidine modification affect the peptide's mechanism or just reduce toxicity?
Common questions
How can bee venom help with pancreatitis?
What is severe acute pancreatitis?
Read the original research
A Melittin-Derived Lead Compound Ameliorates Severe Acute Pancreatitis by Restoring Oxidative Homeostasis and Macrophage Metabolism.
Inflammation, 49(1), 59
Citation
Chen, Xiaolong; Chen, Ya; Mao, Yunyun; Chen, Xinxin; Zhou, Yilin; Tu, Jianfeng. (2026). A Melittin-Derived Lead Compound Ameliorates Severe Acute Pancreatitis by Restoring Oxidative Homeostasis and Macrophage Metabolism.. Inflammation, 49(1), 59. https://doi.org/10.1007/s10753-025-02444-9